NIH-funded research NIH-funded research

A new zebrafish model to study balance issues in progressive supranuclear palsy

Official title: A Phenotype-Optimized Zebrafish Model of Progressive Supranuclear Palsy

Funded at New York University School of Medicine · NIH-10764950 · Data updated 2026-11-12

This study is exploring a new way to understand progressive supranuclear palsy (PSP) by using zebrafish to mimic the brain changes that happen in this condition, which could help researchers find better treatments for people with PSP.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionNew York University School of Medicine
NIH-funded
Lab location1 site (New York, United States)
Project startJanuary 15, 2022
Project endDecember 31, 2025
Funding year2024
Award (this year)$188,955
NIH project number5R33NS125280-03
Project IDNIH-10764950 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals diagnosed with progressive supranuclear palsy who experience significant balance issues.

Less likely to help

Patients with other neurodegenerative diseases that do not involve Tau pathology may not benefit from this research.

What this research studies

This research investigates progressive supranuclear palsy (PSP), a neurodegenerative disease that causes severe balance problems and other neurological symptoms. The team is developing a zebrafish model that mimics the Tau protein pathology associated with PSP, allowing for better understanding and evaluation of potential treatments. By using zebrafish, which are small and have easily observable behaviors, researchers aim to link the underlying biological mechanisms of balance deficits to the symptoms experienced by patients. The model will be validated through various neurological and behavioral tests to ensure its relevance to human PSP.

Why it matters

Potential benefit: If successful, this research could lead to new therapies that improve balance and reduce falls in patients with progressive supranuclear palsy.

How similar studies have gone: Previous research has shown promise in using animal models to study neurodegenerative diseases, suggesting that this approach could yield valuable insights.

Where this research is happening

  • New York University School of Medicine
    New York, United States
    Active

Researchers

  • Principal investigator: Schoppik, David — New York University School of Medicine
  • Study coordinator: Schoppik, David

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.